HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

RIFM symposium

This article was originally published in The Rose Sheet

Executive Summary

"Dermal Sensitization: The Current and Future State of the Science Surrounding This Important Endpoint" is slated to be held by the Research Institute for Fragrance Materials Nov. 7 during the American College of Toxicology annual meeting in Williamsburg, Va. Symposium will include presentation on skin sensitization predictive testing, dose-response relationships and potency assessment. RIFM Scientific Director Anne Marie Api, PhD, and Procter & Gamble Principal Scientist Pauline McNamee, PhD, are among the scheduled speakers...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013294

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel